MADELINE MEE: Open Payments
NPI 1366224792 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 29 payments from 11 companies in 2025. Trend: 2023 $115 · 2024 $441 · 2025 $782
Food & beverage: $747Education: $35
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $417 |
| Aveo Pharmaceuticals, Inc. | 4 | $87 |
| Ferring Pharmaceuticals Inc. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| IMMUNITYBIO, INC. | 1 | $30 |
| Myriad Genetic Laboratories, Inc. | 1 | $22 |
| Incyte Corporation | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: ERLEADA, RYBREVANT, FOTIVDA, ADSTILADRIN, Nubeqa, PYLARIFY, IMFINZI, ANKTIVA.
Industry payments across OK — which companies pay providers there.
